hasCausingCondition – Allowed codes

6C40.1 – Harmful pattern of use of alcohol

6C40.2 – Alcohol dependence

6C41.0 – Episode of harmful use of cannabis

6C41.1 – Harmful pattern of use of cannabis

6C41.2 – Cannabis dependence

6C42.0 – Episode of harmful use of synthetic cannabinoids

6C42.1 – Harmful pattern of use of synthetic cannabinoids

6C42.2 – Synthetic cannabinoid dependence

6C43.0 – Episode of harmful use of opioids

6C43.1 – Harmful pattern of use of opioids

6C43.2 – Opioid dependence

6C44.0 – Episode of harmful use of sedatives, hypnotics or anxiolytics

6C44.1 – Harmful pattern of use of sedatives, hypnotics or anxiolytics

6C44.2 – Sedative, hypnotic or anxiolytic dependence

6C45.0 – Episode of harmful use of cocaine

6C45.1 – Harmful pattern of use of cocaine

6C45.2 – Cocaine dependence

6C46.0 – Episode of harmful use of stimulants including amphetamines, methamphetamine or methcathinone

6C46.1 – Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone

6C46.2 – Stimulant dependence including amphetamines, methamphetamine or methcathinone

6C47.0 – Episode of harmful use of synthetic cathinones

6C47.1 – Harmful pattern of use of synthetic cathinones

6C47.2 – Synthetic cathinone dependence

6C48.0 – Episode of harmful use of caffeine

6C48.1 – Harmful pattern of use of caffeine

6C49.0 – Episode of harmful use of hallucinogens

6C49.1 – Harmful pattern of use of hallucinogens

6C49.2 – Hallucinogen dependence

6C4A.0 – Episode of harmful use of nicotine

6C4A.1 – Harmful pattern of use of nicotine

6C4A.2 – Nicotine dependence

6C4B.0 – Episode of harmful use of volatile inhalants

6C4B.1 – Harmful pattern of use of volatile inhalants

6C4B.2 – Volatile inhalant dependence

6C4C.0 – Episode of harmful use of MDMA or related drugs, including MDA

6C4C.1 – Harmful pattern of use of MDMA or related drugs, including MDA

6C4C.2 – MDMA or related drug dependence, including MDA

6C4D.0 – Episode of harmful use of dissociative drugs including ketamine or PCP

6C4D.1 – Harmful pattern of use of dissociative drugs, including ketamine or PCP

6C4D.2 – Dissociative drug dependence including ketamine or PCP

6C4E.0 – Episode of harmful use of other specified psychoactive substance

6C4E.1 – Harmful pattern of use of other specified psychoactive substance

6C4E.2 – Other specified psychoactive substance dependence

6C4F.0 – Episode of harmful use of multiple specified psychoactive substances

6C4F.1 – Harmful pattern of use of multiple specified psychoactive substances

6C4F.2 – Multiple specified psychoactive substances dependence

6C4G.0 – Episode of harmful use of unknown or unspecified psychoactive substances

6C4G.1 – Harmful pattern of use of unknown or unspecified psychoactive substance

6C4G.2 – Unknown or unspecified psychoactive substance dependence

6D10 – Personality disorder

6D80 – Dementia due to Alzheimer disease

6D81 – Dementia due to cerebrovascular disease

6D82 – Dementia due to Lewy body disease

6D83 – Frontotemporal dementia

6D84 – Dementia due to psychoactive substances including medications

6D85 – Dementia due to diseases classified elsewhere

6D86 – Behavioural or psychological disturbances in dementia

6D8Y – Dementia, other specified cause

6D8Z – Dementia, unknown or unspecified cause

6E62 – Secondary mood syndrome

7A80 – Restless legs syndrome

7A81 – Periodic limb movement disorder

8A00 – Parkinsonism

8A00.0 – Parkinson disease

8A01 – Choreiform disorders

8A01.10 – Huntington disease

8A01.14 – Chorea due to infectious or para-infectious causes

8A02 – Dystonic disorders

8A03 – Ataxic disorders

8A04 – Disorders associated with tremor

8A05 – Tic disorders

8A06 – Myoclonic disorders

8A07 – Certain specified movement disorder

8A07.1 – Akathisia

8A20 – Alzheimer disease

8A21 – Progressive focal atrophies

8A22 – Lewy body disease

8A23 – Frontotemporal lobar degeneration

8A2Y – Other specified disorders with neurocognitive impairment as a major feature

8A2Z – Disorders with neurocognitive impairment as a major feature, unspecified

8A40 – Multiple sclerosis

8A41 – Isolated demyelinating syndromes of the central nervous system

8A42 – Acute disseminated encephalomyelitis

8A43 – Neuromyelitis optica

8A44 – Leukodystrophies

8A45 – Secondary white matter disorders

8A45.01 – Subacute sclerosing panencephalitis

8A45.02 – Progressive multifocal leukoencephalopathy

8A46 – Central demyelination of corpus callosum

8A4Y – Other specified multiple sclerosis or other white matter disorders

8A4Z – Multiple sclerosis or other white matter disorders, unspecified

8A60 – Epilepsy due to structural or metabolic conditions or diseases

8A61 – Genetic or presumed genetic syndromes primarily expressed as epilepsy

8A62 – Epileptic encephalopathies

8A63 – Seizure due to acute causes

8B00 – Intracerebral haemorrhage

8B01 – Subarachnoid haemorrhage

8B11 – Cerebral ischaemic stroke

8B11.1 – Cerebral ischaemic stroke due to intracranial large artery atherosclerosis

8B11.2 – Cerebral ischaemic stroke due to embolic occlusion